VIROPHARMA INC: cashflow_investing
| Value | {"amount": -101934000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2010-01-01 – 2010-12-31 |
| Status | current |
| Entity | VIROPHARMA INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2ee0c9f9-7259-41ef-95e5-d65f8aefe3ff
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-085452 · Open the official SEC filing →Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000946840/cashflow-investing/2010-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2ee0c9f9-7259-41ef-95e5-d65f8aefe3ff
History
- no predecessors — first report